The data will be presented during a poster session at the 2015 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium taking place in San Francisco from January
The study assessed BRILINTA (ticagrelor) tablets at either 60mg twice daily or 90mg twice daily plus low-dose aspirin for the secondary prevention of atherothrombotic events in patients who
The aim of the new collaboration is the research and development of small molecule inhibitors of oncogenic Ras for the treatment of cancer. Ras is the most frequently
Angiogenesis is correlated with disease progression and poor prognosis in many tumor types, such as colon, lung, breast and pancreatic cancers. Two key pathways, VEGF / VEGFR2 (KDR),
If approved, Akorn’s ANDA product would be a generic version of Alcon’s Durezol(R), which is a topical corticosteroid indicated for the treatment of inflammation and pain associated with
The trial enrolled 73 children with mild to moderate atopic dermatitis into a four-week double-blind period, followed by a four-week open label extension for those patients who wish
Hanmi Pharmaceutical also will be making a strategic investment in Allegro that will advance and accelerate the global development program for Luminate. Under the terms of the agreements,
Actavis will immediately begin marketing approximately 20 injectable products across a number of therapeutic categories in the US. The Company will be a leader in Oncology, with nearly
"This new patent allowance is representative of our intellectual property strategy aimed at protecting and enhancing the value of VAL-083," stated Jeffrey Bacha, DelMar’s president and CEO. "This
As life expectancy rises worldwide, Alzheimer’s is becoming an increasingly lethal disease, placing enormous strain on caregivers and healthcare systems. With over 500,000 patients in Canada alone, the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.